CC
AMPE

Chicago Capital’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Chicago Capital’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-369
Closed -$7K – 243
2022
Q3 		$7K Hold
369
– – ﹤0.01% 233
2022
Q2 		$19K Hold
369
– – ﹤0.01% 238
2022
Q1 		$52K Hold
369
– – ﹤0.01% 250
2021
Q4 		$63K Hold
369
– – ﹤0.01% 260
2021
Q3 		$184K Hold
369
– – 0.01% 246
2021
Q2 		$185K Hold
369
– – 0.01% 243
2021
Q1 		$187K Buy
+369
New +$190K 0.01% 237

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Chicago Capital's AMPE Position: Q4 2022 in Review

Chicago Capital sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 369 shares — an estimated $7K sold.

Chicago Capital first reported a position in AMPE in Q1 2021 and held it in 7 quarters. The position peaked at $187K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Chicago Capital reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Chicago Capital sold 369 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $7K.
  • Chicago Capital first reported a position in Ampio Pharmaceuticals Inc. in Q1 2021 and held it in 7 quarters.
  • Chicago Capital's Ampio Pharmaceuticals Inc. position peaked at $187K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Chicago Capital's 13F filing for Q4 2022, filed 20 Jan 2023.